"Polycythemia vera" trang 1 - tải miễn phí từ tailieunhanh
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 7)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 7)

5    56    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 8)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 8)

5    60    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 9)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 9)
5    64    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 10)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 10)
8    57    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 1)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 1)

5    64    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 2)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 2)

5    59    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 3)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 3)

5    54    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 4)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 4)

5    60    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 5)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 5)

5    58    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 6)

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 6)

5    60    0
Impact of JAK2V617F mutation burden on disease phenotype in Chinese patients with JAK2V617F-positive Polycythemia vera (PV) and Essential thrombocythemia (ET)

Impact of JAK2V617F mutation burden on disease phenotype in Chinese patients with JAK2V617F-positive Polycythemia vera (PV) and Essential thrombocythemia (ET)
7    75    0
Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018

Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018
15    88    0
Cytoreductive treatment patterns among US veterans with polycythemia vera

Cytoreductive treatment patterns among US veterans with polycythemia vera
7    34    1
Gene expressions involved in immune system control and serum CA125 content in polycythemia vera

Gene expressions involved in immune system control and serum CA125 content in polycythemia vera
10    57    1
A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: A case report

A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: A case report
6    49    1
Báo cáo y học:

Báo cáo y học: " Polycythemia vera as a presentation of renal angiomyolipoma: a case report"
3    45    0
Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases
17    58    0
báo cáo hóa học:

báo cáo hóa học:" Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a"
17    58    0
Impact of Myeloproliferative neoplasms on patients’ employment status and work productivity in the United States: Results from the living with MPNs survey

Impact of Myeloproliferative neoplasms on patients’ employment status and work productivity in the United States: Results from the living with MPNs survey
9    45    1
A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms

A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
9    68    1